Armin Ghobadi Selected Research

Armin Ghobadi Research Topics

Disease

16	Neoplasms (Cancer) 06/2022 - 01/2017
11	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 12/2017
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2014
7	Lymphoma (Lymphomas) 10/2022 - 12/2016
6	Multiple Myeloma 01/2022 - 05/2013
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2019
5	Cytokine Release Syndrome 10/2022 - 01/2017
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2022 - 12/2017
4	Leukemia 01/2022 - 10/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2016
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 12/2017
3	Residual Neoplasm 01/2021 - 12/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 06/2015
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 06/2015
2	Infections 12/2017 - 12/2016
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	cell-associated neurotoxicity 01/2021
1	Bites and Stings (Sting) 01/2021
1	Leukocytosis (Pleocytosis) 01/2021
1	Pancreatitis 01/2021
1	Philadelphia Chromosome 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Inflammation (Inflammations) 10/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020
1	Body Weight (Weight, Body) 12/2017
1	Smoldering Multiple Myeloma 01/2017
1	Pathologic Complete Response 12/2016
1	Hodgkin Disease (Hodgkin's Disease) 12/2016
1	Fever (Fevers) 12/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2016

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 10/2022 - 12/2017
12	axicabtagene ciloleucelIBA 10/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	Monoclonal AntibodiesIBA 01/2022 - 01/2019
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2021
2	AntigensIBA 01/2022 - 01/2021
2	blinatumomabIBA 01/2021 - 12/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 10/2019
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 10/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 12/2017
2	Bendamustine Hydrochloride FDA Link 10/2020 - 05/2020
2	tisagenlecleucelIBA 11/2019 - 01/2019
2	Bortezomib (Velcade)FDA Link 10/2019 - 01/2019
2	Decitabine FDA Link 12/2017 - 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Alkylating AgentsIBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	CytokinesIBA 01/2022
1	ALT-803IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	brexucabtagene autoleucelIBA 01/2021
1	plerixafor FDA Link 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2020
1	Calcineurin InhibitorsIBA 12/2020
1	Methotrexate (Mexate)FDA LinkGeneric 12/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2020
1	Rituximab (Mabthera)FDA Link 10/2020
1	PENTAIBA 05/2020
1	Prednisone (Sone)FDA LinkGeneric 05/2020
1	selinexorIBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Filgrastim (Neupogen)FDA Link 01/2020
1	ruxolitinibIBA 01/2020
1	1-dodecylpyridoxal (PLD)IBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	carfilzomibIBA 01/2019
1	liposomal doxorubicin (Doxil)FDA Link 01/2019
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2018
1	fludarabineIBA 12/2017
1	Etoposide (VP 16)FDA LinkGeneric 12/2016
1	ElectrolytesIBA 12/2016
1	Carmustine (FIVB)FDA Link 12/2016
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 12/2016
1	Melphalan (Alkeran)FDA LinkGeneric 12/2016
1	9-(4-fluoro-3-hydroxymethylbutyl)guanineIBA 06/2015
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2013
8	Stem Cell Transplantation 01/2022 - 06/2015
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
5	Immunotherapy 01/2022 - 01/2019
4	Cell Transplantation 01/2022 - 05/2013
4	Transplantation 12/2020 - 01/2019
3	Organ Transplantation 01/2021 - 01/2017
2	Salvage Therapy 05/2020 - 12/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Hematopoietic Stem Cell Mobilization 10/2019
1	BEAM regimen 12/2016
1	Homologous Transplantation 02/2014